- Home
- NAAS vs SBFM Comparison
NAAS vs SBFM Comparison
Compare NAAS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- SBFM
- Stock Information
- Founded
- NAAS 2019
- SBFM 2006
- Country
- NAAS China
- SBFM United States
- Employees
- NAAS N/A
- SBFM N/A
- Industry
- NAAS Other Specialty Stores
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- NAAS Consumer Discretionary
- SBFM Health Care
- Exchange
- NAAS Nasdaq
- SBFM Nasdaq
- Market Cap
- NAAS 8.3M
- SBFM 6.6M
- IPO Year
- NAAS 2017
- SBFM N/A
- Fundamental
- Price
- NAAS $2.75
- SBFM $1.40
- Analyst Decision
- NAAS
- SBFM Strong Buy
- Analyst Count
- NAAS 0
- SBFM 1
- Target Price
- NAAS N/A
- SBFM $15.00
- AVG Volume (30 Days)
- NAAS 142.5K
- SBFM 47.2K
- Earning Date
- NAAS 09-05-2025
- SBFM 11-04-2025
- Dividend Yield
- NAAS N/A
- SBFM N/A
- EPS Growth
- NAAS N/A
- SBFM N/A
- EPS
- NAAS N/A
- SBFM N/A
- Revenue
- NAAS $27,534,354.00
- SBFM $36,341,741.00
- Revenue This Year
- NAAS $378.49
- SBFM $32.20
- Revenue Next Year
- NAAS N/A
- SBFM $32.74
- P/E Ratio
- NAAS N/A
- SBFM N/A
- Revenue Growth
- NAAS N/A
- SBFM 19.22
- 52 Week Low
- NAAS $1.96
- SBFM $1.17
- 52 Week High
- NAAS $74.40
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- NAAS 44.36
- SBFM 44.01
- Support Level
- NAAS $3.04
- SBFM $1.35
- Resistance Level
- NAAS $3.85
- SBFM $1.45
- Average True Range (ATR)
- NAAS 0.32
- SBFM 0.07
- MACD
- NAAS -0.00
- SBFM -0.00
- Stochastic Oscillator
- NAAS 5.31
- SBFM 27.78
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.